Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.

Beernink JM, Heerspink HJL, Birkenfeld AL, Cherney DZI, Colhoun HM, Groop PH, Ji L, Mathieu C, Rosas SE, Tuttle KR, Skyler JS, Amor AJ, Caramori ML, Fiorina P, Jongs N, Pagotto U, Setola E, Brinker M, Lawatscheck R, Russel J, Schloemer P, McGill JB, Rossing P, FINE-ONE investigators*

Open source

DOI: 10.2337/dc26-0882
Published: 2026 Aug 1
Container: Diabetes care
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2337/dc26-0882,
  title = {Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.},
  author = {Beernink JM and Heerspink HJL and Birkenfeld AL and Cherney DZI and Colhoun HM and Groop PH and Ji L and Mathieu C and Rosas SE and Tuttle KR and Skyler JS and Amor AJ and Caramori ML and Fiorina P and Jongs N and Pagotto U and Setola E and Brinker M and Lawatscheck R and Russel J and Schloemer P and McGill JB and Rossing P and FINE-ONE investigators*},
  year = {2026},
  journal = {Diabetes care},
  doi = {10.2337/dc26-0882},
  url = {https://doi.org/10.2337/dc26-0882}
}

RIS

TY  - JOUR
TI  - Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.
AU  - Beernink JM
AU  - Heerspink HJL
AU  - Birkenfeld AL
AU  - Cherney DZI
AU  - Colhoun HM
AU  - Groop PH
AU  - Ji L
AU  - Mathieu C
AU  - Rosas SE
AU  - Tuttle KR
AU  - Skyler JS
AU  - Amor AJ
AU  - Caramori ML
AU  - Fiorina P
AU  - Jongs N
AU  - Pagotto U
AU  - Setola E
AU  - Brinker M
AU  - Lawatscheck R
AU  - Russel J
AU  - Schloemer P
AU  - McGill JB
AU  - Rossing P
AU  - FINE-ONE investigators*
PY  - 2026
JO  - Diabetes care
DO  - 10.2337/dc26-0882
UR  - https://doi.org/10.2337/dc26-0882
ER  -

APA

JM, B., HJL, H., AL, B., DZI, C., HM, C., PH, G., L, J., C, M., SE, R., KR, T., JS, S., AJ, A., ML, C., P, F., N, J., U, P., E, S., M, B., R, L., J, R., P, S., JB, M., P, R., & investigators*, F. (2026). Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.. Diabetes care. https://doi.org/10.2337/dc26-0882

Source records

pubmed · retrieved 2026-11-10T08:42:19.866Z